Beta-Blockers after Myocardial Infarction - The New England Journal of Medicine
NEJM • 2/18/2026 – 2/19/2026
Summary
The article titled "Beta-Blockers after Myocardial Infarction" is published in The New England Journal of Medicine. It discusses the use of beta-blockers following a myocardial infarction.
Advertisement
Lindy Score Breakdown (V4.2)
49d
Age
1
Sources
from cluster
1163
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1163/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1163/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 48 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Everyone agrees AI scribes are increasing health care costs. No one agrees what to do about it
Stat News • Today
STAT+: FDA backs proposals to entice pharma companies to test, make drugs domestically
Stat News • 1 day ago
STAT+: UnitedHealth Group is making a $3 billion bet on AI. What does it mean for patients?
Stat News • 2 days ago
STAT+: A key Medicare Advantage announcement is due today
Stat News • 2 days ago
Smart contact lens monitors eye pressure and delivers glaucoma drugs as needed
Stat News • Today
STAT+: Steve Ubl to step down as CEO of PhRMA
Stat News • Today
A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career
Stat News • 1 day ago
UnitedHealth makes a bet on AI. What does it mean for us?
Stat News • 2 days ago
Opinion: ‘Medical nutrition’ helps keep my son, and many others, healthy. But insurance won’t cover it
Stat News • 2 days ago
Opinion: STAT+: Former Geisinger CEO: U.S. health systems must replace huge numbers of people with AI
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 6 days ago
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • 5 days ago
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Stat News • 5 days ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 2 weeks ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 6 days ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 2 weeks ago